Literature DB >> 30284220

Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial.

W-Y Cai1, J-S Gao2, X Luo1, H-L Ma2, H Ge1, N Liu1, Q Xia1, Y Wang2, B-W Han1, X-K Wu3.   

Abstract

PURPOSE: To investigate the effects of metabolic abnormalities, hyperandrogenemia and ovulation induction by clomiphene/acupuncture on liver function parameters among women with polycystic ovary syndrome (PCOS).
METHODS: This is a secondary analysis of a randomized controlled trial. All 1000 subjects were diagnosed as PCOS by modified Rotterdam criteria. Liver function parameters, metabolic panel and hormone profile were measured at baseline and after treatment. The relationship between liver parameters with metabolic, hormonal parameters and ovulation induction was examined.
RESULTS: PCOS women with metabolic syndrome had higher liver enzyme levels but lower bilirubin and bile acid levels than without. PCOS women with hyperandrogenemia had higher liver enzyme, bilirubin levels than without. Correlation analyses showed that worsening of metabolic parameters was associated with higher liver enzyme levels but lower bilirubin and bile acid levels, while increased androgen levels were associated with higher liver enzyme, bilirubin and bile acid levels. Ovulation induction with clomiphene citrate could decrease bilirubin and bile acid levels, while acupuncture had no obvious effect on liver function.
CONCLUSIONS: Among PCOS women, metabolic abnormalities and hyperandrogenemia impaired different liver function parameters. Clomiphene could decrease the bilirubin and bile acid levels while acupuncture had no obvious effect on liver function.

Entities:  

Keywords:  Hyperandrogenemia; Liver function; Metabolic syndrome; Ovulation induction; PCOS

Mesh:

Substances:

Year:  2018        PMID: 30284220     DOI: 10.1007/s40618-018-0953-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  2 in total

1.  Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women with Polycystic Ovary Syndrome.

Authors:  Xi Luo; Xin-Ming Yang; Wang-Yu Cai; Hui Chang; Hong-Li Ma; Yan Peng; Xiao-Ke Wu
Journal:  Int J Endocrinol       Date:  2020-06-25       Impact factor: 3.257

2.  Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).

Authors:  A Podfigurna; B Meczekalski; F Petraglia; S Luisi
Journal:  J Endocrinol Invest       Date:  2019-10-25       Impact factor: 5.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.